stockportfolio.pro
Globus Medical, Inc. P/E Ratio 2010–2025
Globus Medical, Inc. (GMED) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +3.6%/yr over 15 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 22.27 | -79.8% |
| FY 2024 | 110.28 | +121.4% |
| FY 2023 | 49.80 | +24.1% |
| FY 2022 | 40.15 | -19.9% |
| FY 2021 | 50.14 | -22.4% |
| FY 2020 | 64.57 | +66.7% |
| FY 2019 | 38.74 | +37.8% |
| FY 2018 | 28.10 | -24.8% |
| FY 2017 | 37.36 | +62.6% |
| FY 2016 | 22.97 | -3.4% |
| FY 2015 | 23.78 | -3.0% |
| FY 2014 | 24.51 | -11.4% |
| FY 2013 | 27.64 | +110.8% |
| FY 2012 | 13.11 | — |
| FY 2011 | — | — |
| FY 2010 | — | — |
Source: Globus Medical, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Globus Medical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeGlobus Medical, Inc. — frequently asked questions
What is Globus Medical, Inc.'s price-to-earnings ratio?
Globus Medical, Inc. (GMED) reported price-to-earnings ratio of 22.27 for fiscal year 2025, per its SEC filings.
How has Globus Medical, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2010 and 2025, GMED's price-to-earnings ratio grew at roughly 3.6% per year (compound annual rate), from 13.11 to 22.27.
Where does this data come from?
Figures are computed from Globus Medical, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.